VIE/BAX (VIE/BAX)

Vienna Stock Exchange: VIE/BAX · EUR

€21.5

-1.34 (-5.9%)· Recorded snapshot

Market cap	11.8B
Revenue (ttm)	10.2B
Net income (ttm)	-636.7M
EPS (ttm)	-€1.26
P/E (forward)	12.3x
Dividend	€0.03 (0.16%)
Volume	485

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.2B
Net income (ttm): -636.7M
EPS (ttm): -€1.26
P/E (forward): 12.3x
Market cap: 11.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E12.3

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-14.4

P25 4.8P50 10.6P75 20.1

ROIC8.2

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

S&P 500+0.6%

Nasdaq Composite-2.3%

Dow Jones Industrial Average+1.9%

Russell 2000+1.8%

All VIE/BAX indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-29
Employees	37,500
Employees change	-500
Employees growth	-1.32%
Enterprise value	EUR 18.5B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1931
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	US0718131099
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Market cap	EUR 11.8B
Next earnings date	2026-10-29
Price	EUR 21.49
Price currency	EUR
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-29
Symbol	vie/BAX
Website	https://www.baxter.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	36.63x
Earnings yield	-5.85%
EV/EBIT	18.37x
EV/EBITDA	9.83x
EV/FCF	25.38x
EV/Sales	1.78x
FCF / EV yield	3.94%
FCF yield	6.18%
Forward P/E	12.29x
P/(FCF - SBC) ratio	18.83x
P/(OCF - SBC) ratio	10.95x
P/B ratio	2.17x
P/FCF ratio	16.18x
P/OCF ratio	10x
P/S ratio	1.16x
Price/EBITDA ratio	6.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.68%
EBITDA margin	17.92%
FCF margin	7.11%
Gross margin	35.6%
Operating margin	9.68%
Pretax margin	-1.61%
Profit margin	-6.23%
Profit per employee	EUR -16,978
Profitable quarters	1
Revenue per employee	EUR 272,657
ROA	2.85%
ROA (5Y)	2.55%
ROCE	5.75%
ROE	-14.37%
ROE (5Y)	-9.06%
ROIC	8.21%
ROIC (5Y)	5.41%
SBC / revenue	1%
Tax / revenue	3.72%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	131.76%
EPS growth quarters	1
EPS growth years	0
FCF growth	243.88%
FCF growth 3Y	-2.82%
FCF growth 5Y	-9.65%
Gross profit growth	-1.15%
Gross profit growth (Q)	-2.64%
Gross profit growth 3Y	-2.98%
Gross profit growth 5Y	-3.89%
Net income growth (QoQ)	133.33%
Net income growth quarters	1
Net income growth years	0
OCF growth	72.42%
OCF growth 10Y	-0.51%
OCF growth 3Y	-5.42%
OCF growth 5Y	-8.67%
Operating income growth	3.31%
Operating income growth (Q)	-21.6%
Operating income growth 3Y	1.28%
Operating income growth 5Y	-10.73%
Revenue growth	5.33%
Revenue growth (Q)	4.97%
Revenue growth (QoQ)	0.54%
Revenue growth 10Y	1.38%
Revenue growth 3Y	0.68%
Revenue growth 5Y	-1.39%
Revenue growth quarters	8
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -451.5M
Depreciation and amortization	EUR 857.3M
EBIT	EUR 989.8M
EBITDA	EUR 1.8B
EPS	EUR -1.26
Financing cash flow	EUR -241.9M
Free cash flow	EUR 730.1M
Free cash flow minus SBC	EUR 627M
Gross profit	EUR 3.6B
Income taxes	EUR 380.4M
Investing cash flow	EUR -500.7M
Net borrowing	EUR 12.5M
Net cash flow	EUR 419.2M
Net income	EUR -636.7M
Operating cash flow minus SBC	EUR 1.1B
Operating income	EUR 989.8M
Revenue	EUR 10.2B
Stock-based compensation	EUR 103M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 10.57
Debt / EBITDA	4.6
Debt / equity	1.56
Debt / FCF	11.66
Interest coverage	3.73
Net cash (debt)	EUR -6.6B
Net cash / market cap	-56.05%
Net debt / EBITDA	3.61
Net debt / equity	1.22
Net debt / FCF	9.07
Piotroski F-Score	4
Shareholders' equity	EUR 5.4B
Tangible book value	EUR -2.4B
Tangible book value per share	EUR -4.69
Total cash	EUR 1.9B
Total debt	EUR 8.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.56
Current ratio	1.95
Inventory turnover	3.26
Quick ratio	1.13
Working capital	EUR 3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.44%
Dividend growth	-94.47%
Dividend growth (3Y)	-68.45%
Dividend growth (5Y)	-47.64%
Dividend growth years	0
Dividend payment date	2026-10-01
Dividend payment years	10
Dividend payout frequency	Quarterly
Dividend per share	EUR 0.03
Dividend yield	0.16%
Ex-dividend date	2026-08-28
Last dividend	EUR 0.01
Shareholder yield	-0.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 19.11
1D price change	-5.87%
1M price change	10.56%
1M total return	10.56%
1W price change	4.77%
1W total return	4.77%
1Y price change	16.48%
1Y return CAGR	16.71%
1Y total return	16.7%
20-day SMA	EUR 21.95
200-day SMA	EUR 18.47
3M price change	6.83%
3M total return	6.87%
3Y price change	-25.51%
3Y return CAGR	-7.65%
3Y total return	-21.25%
50-day SMA	EUR 21.62
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 24.64
52-week high date	2026-08-05
52-week low	EUR 13.86
52-week low date	2026-03-30
5Y price change	-67.74%
5Y return CAGR	-18.67%
5Y total return	-64.41%
6M price change	46.35%
6M total return	46.48%
All-time high	EUR 86.78
All-time high date	2020-04-20
All-time low	EUR 13.86
All-time low date	2026-03-30
Average true range (ATR)	EUR 0.61
Average volume	24.3
Change from 52-week high	-12.78%
Change from 52-week low	55.01%
Change from all-time high	-73.69%
Change from all-time low	64.67%
Change from open	-8.12%
Day's gap	2.45%
Dollar volume	EUR 10,423
High price	EUR 23.80
Low price	EUR 21.49
Monthly RSI	44.58
Open price	EUR 23.39
Position in 52-week range	0%
Previous close	EUR 22.83
Price vs 150-day SMA	19.49%
Price vs 20-day SMA	4.01%
Price vs 200-day SMA	23.62%
Price vs 50-day SMA	5.58%
Relative volume	20
RSI	46.84
Sharpe ratio	0.34
Sharpe ratio (3Y)	-0.2
Sharpe ratio (5Y)	-0.6
Sortino ratio	0.6
Sortino ratio (3Y)	-0.12
Sortino ratio (5Y)	-0.62
Volume	485
Weekly RSI	55.39
YTD price change	39.29%
YTD total return	39.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	514.4M
Shares change (QoQ)	0.39%
Shares change (YoY)	0.44%
Shares held by insiders	0.42%
Shares held by institutions	109.68%

Deeper analysis on VIE/BAX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this VIE/BAX report

Is a complete VIE/BAX research report available?

No complete published report is available for vie/BAX (VIE/BAX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

11.8B

Revenue (ttm)

10.2B

Net income (ttm)

-636.7M

EPS (ttm)

-€1.26

P/E (forward)

12.3x

Dividend

€0.03 (0.16%)

Volume

485

Metric

Value

Amount currency

EUR

Country

United States

Country code

Earnings date

2026-10-29

Employees

37,500

Employees change

-500

Employees growth

-1.32%

Enterprise value

EUR 18.5B

Exchange

Vienna Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1931

Industry

Medical Instruments & Supplies

Is primary listing

ISIN number

US0718131099

Last earnings date

2026-10-29

Last refreshed

2026-10-29

Market cap

EUR 11.8B

Next earnings date

2026-10-29

Price

EUR 21.49

Price currency

EUR

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-29

Symbol

vie/BAX

Website

https://www.baxter.com

Metric

Value

Average P/E ratio (10Y)

36.63x

Earnings yield

-5.85%

EV/EBIT

18.37x

EV/EBITDA

9.83x

EV/FCF

25.38x

EV/Sales

1.78x

FCF / EV yield

3.94%

FCF yield

6.18%

Forward P/E

12.29x

P/(FCF - SBC) ratio

18.83x

P/(OCF - SBC) ratio

10.95x

P/B ratio

2.17x

P/FCF ratio

16.18x

P/OCF ratio

10x

P/S ratio

1.16x

Price/EBITDA ratio

6.44x

Metric

Value

EBIT margin

9.68%

EBITDA margin

17.92%

FCF margin

7.11%

Gross margin

35.6%

Operating margin

9.68%

Pretax margin

-1.61%

Profit margin

-6.23%

Profit per employee

EUR -16,978

Profitable quarters

Revenue per employee

EUR 272,657

ROA

2.85%

ROA (5Y)

2.55%

ROCE

5.75%

ROE

-14.37%

ROE (5Y)

-9.06%

ROIC

8.21%

ROIC (5Y)

5.41%

SBC / revenue

Tax / revenue

3.72%

Metric

Value

EPS growth (QoQ)

131.76%

EPS growth quarters

EPS growth years

FCF growth

243.88%

FCF growth 3Y

-2.82%

FCF growth 5Y

-9.65%

Gross profit growth

-1.15%

Gross profit growth (Q)

-2.64%

Gross profit growth 3Y

-2.98%

Gross profit growth 5Y

-3.89%

Net income growth (QoQ)

133.33%

Net income growth quarters

Net income growth years

OCF growth

72.42%

OCF growth 10Y

-0.51%

OCF growth 3Y

-5.42%

OCF growth 5Y

-8.67%

Operating income growth

3.31%

Operating income growth (Q)

-21.6%

Operating income growth 3Y

1.28%

Operating income growth 5Y

-10.73%

Revenue growth

5.33%

Revenue growth (Q)

4.97%

Revenue growth (QoQ)

0.54%

Revenue growth 10Y

1.38%

Revenue growth 3Y

0.68%

Revenue growth 5Y

-1.39%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

EUR -451.5M

Depreciation and amortization

EUR 857.3M

EBIT

EUR 989.8M

EBITDA

EUR 1.8B

EPS

EUR -1.26

Financing cash flow

EUR -241.9M

Free cash flow

EUR 730.1M

Free cash flow minus SBC

EUR 627M

Gross profit

EUR 3.6B

Income taxes

EUR 380.4M

Investing cash flow

EUR -500.7M

Net borrowing

EUR 12.5M

Net cash flow

EUR 419.2M

Net income

EUR -636.7M

Operating cash flow minus SBC

EUR 1.1B

Operating income

EUR 989.8M

Revenue

EUR 10.2B

Stock-based compensation

EUR 103M

Metric

Value

Book value per share

EUR 10.57

Debt / EBITDA

4.6

Debt / equity

1.56

Debt / FCF

11.66

Interest coverage

3.73

Net cash (debt)

EUR -6.6B

Net cash / market cap

-56.05%

Net debt / EBITDA

3.61

Net debt / equity

1.22

Net debt / FCF

9.07

Piotroski F-Score

Shareholders' equity

EUR 5.4B

Tangible book value

EUR -2.4B

Tangible book value per share

EUR -4.69

Total cash

EUR 1.9B

Total debt

EUR 8.5B

Metric

Value

Asset turnover

0.56

Current ratio

1.95

Inventory turnover

3.26

Quick ratio

1.13

Working capital

EUR 3B

Metric

Value

Buyback yield / dilution

-0.44%

Dividend growth

-94.47%

Dividend growth (3Y)

-68.45%

Dividend growth (5Y)

-47.64%

Dividend growth years

Dividend payment date

2026-10-01

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

EUR 0.03

Dividend yield

0.16%

Ex-dividend date

2026-08-28

Last dividend

EUR 0.01

Shareholder yield

-0.29%

Metric

Value

150-day SMA

EUR 19.11

1D price change

-5.87%

1M price change

10.56%

1M total return

10.56%

1W price change

4.77%

1W total return

4.77%

1Y price change

16.48%

1Y return CAGR

16.71%

1Y total return

16.7%

20-day SMA

EUR 21.95

200-day SMA

EUR 18.47

3M price change

6.83%

3M total return

6.87%

3Y price change

-25.51%

3Y return CAGR

-7.65%

3Y total return

-21.25%

50-day SMA

EUR 21.62

50-day SMA vs 200-day SMA

50over200

52-week high

EUR 24.64

52-week high date

2026-08-05

52-week low

EUR 13.86

52-week low date

2026-03-30

5Y price change

-67.74%

5Y return CAGR

-18.67%

5Y total return

-64.41%

6M price change

46.35%

6M total return

46.48%

All-time high

EUR 86.78

All-time high date

2020-04-20

All-time low

EUR 13.86

All-time low date

2026-03-30

Average true range (ATR)

EUR 0.61

Average volume

24.3

Change from 52-week high

-12.78%

Change from 52-week low

55.01%

Change from all-time high

-73.69%

Change from all-time low

64.67%

Change from open

-8.12%

Day's gap

2.45%

Dollar volume

EUR 10,423

High price

EUR 23.80

Low price

EUR 21.49

Monthly RSI

44.58

Open price

EUR 23.39

Position in 52-week range

Previous close

EUR 22.83

Price vs 150-day SMA

19.49%

Price vs 20-day SMA

4.01%

Price vs 200-day SMA

23.62%

Price vs 50-day SMA

5.58%

Relative volume

RSI

46.84

Sharpe ratio

0.34

Sharpe ratio (3Y)

-0.2

Sharpe ratio (5Y)

-0.6

Sortino ratio

0.6

Sortino ratio (3Y)

-0.12

Sortino ratio (5Y)

-0.62

Volume

485

Weekly RSI

55.39

YTD price change

39.29%

YTD total return

39.48%

Metric

Value

Float

514.4M

Shares change (QoQ)

0.39%

Shares change (YoY)

0.44%

Shares held by insiders

0.42%

Shares held by institutions

109.68%

VIE/BAX (VIE/BAX)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/BAX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/BAX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/BAX

Frequently asked questions

VIE/BAX (VIE/BAX)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/BAX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/BAX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/BAX

Frequently asked questions